Day: July 3, 2024

Ling LiuAndy HoJuly 3, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips’ Executive Committee, reporting to Philips CEO Roy Jakobs. She succeeds Andy Ho, who has decided to retire after a long and successful career. Ms Liu and Mr Ho continue to work together to ensure a smooth handover. “Ling is a talented, trusted leader and I am delighted that she will join Philips’ Executive Committee as the Chief Region Leader of Philips Greater China,” said Roy Jakobs, CEO of Royal Philips. “She is a proven executive who brings a wealth of international experience and deep HealthTech expertise in China. I would also...

In June 2024 AS Tallink Grupp transported 570,803 passengers, which is a 3.7% decrease compared to June 2023. The number of cargo units decreased by 8.5% to 25,383 units and the number of passenger vehicles decreased by 9.8% to 86,651 units in the same comparison. In the second quarter of 2024 (April-June) AS Tallink Grupp transported 1,451,768 passengers, which is a 5.8% decrease compared to the same period a year ago. The number of cargo units increased by 1.7% to 86,813 units and the number of passenger vehicles decreased by 11.4% to 209,760 units in the same comparison. AS Tallink Grupp passenger, cargo unit and passenger vehicles numbers for June 2024 and the second quarter of the year were the following:  June 2024 June 2023 Change Q2 2024 Q2 2023 ChangePassengers 570,803 592,887 -3.7% 1,451,768 1,541,081...

In June 2024 AS Tallink Grupp transported 570,803 passengers, which is a 3.7% decrease compared to June 2023. The number of cargo units decreased by 8.5% to 25,383 units and the number of passenger vehicles decreased by 9.8% to 86,651 units in the same comparison. In the second quarter of 2024 (April-June) AS Tallink Grupp transported 1,451,768 passengers, which is a 5.8% decrease compared to the same period a year ago. The number of cargo units increased by 1.7% to 86,813 units and the number of passenger vehicles decreased by 11.4% to 209,760 units in the same comparison. AS Tallink Grupp passenger, cargo unit and passenger vehicles numbers for June 2024 and the second quarter of the year were the following:  June 2024 June 2023 Change Q2 2024 Q2 2023 ChangePassengers 570,803 592,887 -3.7% 1,451,768 1,541,081 -5.8%Finland–Sweden 154,413 182,237 -15.3% 355,435 449,886 -21.0%Estonia–Finland 336,430 348,053 -3.3% 922,357 921,353 0.1%Estonia–Sweden 79,960 62,597 27.7% 173,976 169,842 2.4%             Cargo...

23, Place des Carmes-Déchaux – 63000 CLERMONT-FERRAND Information about securities repurchasing programRegulated informationIssuer social denomination: Michelin – LEI 549300SOSI58J6VIW052 Types of securities: ordinary shares – Code ISIN FR 0000121261Date : July 3rd, 2024Issuer Name Issuer code Transaction date ISIN Code Daily total volume (in number of actions) Daily weighted average price of shares acquired PlatformCompagnie Générale des Etablissements Michelin 549300SOSI58J6VIW052 03.07.2024 FR001400AJ45 168 678 35,6659 euros Gré à gréCompagnie Générale des Etablissements Michelin 549300SOSI58J6VIW052 03.07.2024 FR001400AJ45 168 678 35,6659 euros Gré à gréIssuer Name Issuer code PSIName Issuer Code Transaction date   ISIN Code Unit Price Currency ...

In June 2024 AS Tallink Grupp transported 570,803 passengers, which is a 3.7% decrease compared to June 2023. The number of cargo units decreased by 8.5% to 25,383 units and the number of passenger vehicles decreased by 9.8% to 86,651 units in the same comparison. In the second quarter of 2024 (April-June) AS Tallink Grupp transported 1,451,768 passengers, which is a 5.8% decrease compared to the same period a year ago. The number of cargo units increased by 1.7% to 86,813 units and the number of passenger vehicles decreased by 11.4% to 209,760 units in the same comparison. AS Tallink Grupp passenger, cargo unit and passenger vehicles numbers for June 2024 and the second quarter of the year were the following:  June 2024 June 2023 Change Q2 2024 Q2 2023 ChangePassengers 570,803 592,887 -3.7% 1,451,768 1,541,081...

NACON                                                 THIS PRESS RELEASE MUST NOT BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN. THIS PRESS RELEASE IS FOR INFORMATION ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR AN INVITATION TO BUY SECURITIES IN ANY JURISDICTION.                                                                                      Press releaseLesquin, 3 July 2024, 8.00 am NACON LAUNCHES RIGHTS ISSUE WITH PRE-EMPTIVE RIGHTS OF APPROXIMATELY €16.50 MILLION, WHICH MAY BE INCREASED TO €19 MILLION IF THE EXTENSION OPTION IS EXERCISED IN FULL Main termsIssue with pre-emptive rights for shareholders Subscription price: €1.10 per share, representing a discount of 7.3% to the closing price on 1 July 2024 Subscription ratio: 47 pre-emptive rights give the right...

Dupixent approved in the EU as the first-ever targeted therapy for patients with COPDFirst-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life Dupixent is the first new treatment approach for COPD in more than a decade and a new option for approximately 220,000 adults in the EU Approval represents the sixth approved indication for Dupixent in the EU and seventh approved indication globallyParis and Tarrytown, NY, July 3, 2024. The European Medicines Agency (EMA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised...

First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life Dupixent is the first new treatment approach for COPD in more than a decade and a new option for approximately 220,000 adults in the European Union (EU) Approval represents the sixth approved indication for Dupixent in the EU and seventh approved indication globally TARRYTOWN, N.Y. and PARIS, July 03, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has approved Dupixent® (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD)...

MONTRÉAL, July 02, 2024 (GLOBE NEWSWIRE) — North American lithium producer Sayona Mining Limited (“Sayona”) (ASX:SYA; OTCQB:SYAXF) is pleased to announce that Mr. Lucas Dow has been appointed to the role of Managing Director and Chief Executive Officer (MD & CEO) effective 3 July 2024. Lucas first joined the Board as a Non-Executive Director on 14 February 2024 and will now assume the MD & CEO role with a hand over from Interim CEO, James Brown. It is expected James will remain as an Executive Director until 31 January 2025 to facilitate the hand over and business continuity after which he will return to a Non-Executive Director role. Lucas is a highly experienced mining executive with a proven track record of outstanding performance across a diverse range of businesses, commodities and geographies, skills which will...